A Cancer Patient Is In Remission Thanks To One Genetically Engineered Immune Cell – IFLScience
IFLScience |
A Cancer Patient Is In Remission Thanks To One Genetically Engineered Immune Cell
IFLScience Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of certain blood cancers in the mere seven years since it was first tested in a human patient and is on track to be applied to numerous other aggressive cancers soon. |
